Literature DB >> 31606374

Real-time PCR to differentiate among Leishmania (Viannia) subgenus, Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis: Application on Brazilian clinical samples.

Aurora Diotallevi1, Gloria Buffi1, Marcello Ceccarelli1, Herintha Coeto Neitzke-Abreu2, Laisa Vieira Gnutzmann2, Manoel Sebastião da Costa Lima3, Alice Di Domenico1, Mauro De Santi1, Mauro Magnani1, Luca Galluzzi4.   

Abstract

Leishmaniasis is a complex disease caused by Leishmania species belonging to subgenera Leishmania and Viannia. In South America, L. (L.) infantum is considered the most important causative agent of visceral leishmaniasis, while L. (L.) amazonensis and Viannia subgenus species are responsible for the different cutaneous or mucocutaneous forms. In our previous work, we developed a diagnostic approach for Leishmania species discrimination based on two qPCRs (qPCR-ML and qPCR-ama) targeting the minicircle kDNA followed by melting analysis. This approach allowed to (i) differentiate the subgenera Leishmania and Viannia, and (ii) distinguish between L. (L.) infantum and L. (L.) amazonensis. The aim of this work was to demonstrate the applicability of the approach previously described, using human and canine clinical samples and strains from a Brazilian region, where L. (L.) infantum, L. (L.) amazonensis and Viannia subgenus species coexist. After validation on New World strains, the diagnostic approach was applied blindly to 36 canine clinical samples (peripheral blood and bone marrow) and 11 human clinical samples (peripheral blood and bone marrow). The sensitivity was 95.6% (95% confidence interval 77.3-100%) and 100% (95% confidence interval 76.9-100%) in the canine bone marrow samples and human (peripheral blood and bone marrow) samples, respectively, compared to conventional PCR assays. Concerning the Leishmania species identification, the conventional and qPCR-based methods showed kappa value of 0.876 (95% confidence interval 0.638-1.000), indicating good agreement. Therefore, this approach proved to be useful in both veterinary and human clinical context in regions co-endemic for L. (L.) infantum, L. (L.) amazonensis, and Viannia subgenus, helping to provide rapid diagnosis and to allow studies of species distribution.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnostics; HRM; Leishmania amazonensis; Leishmania infantum; Minicircle kDNA; Viannia; qPCR

Year:  2019        PMID: 31606374     DOI: 10.1016/j.actatropica.2019.105178

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  5 in total

1.  Comparative analysis of the transcriptional responses of five Leishmania species to trivalent antimony.

Authors:  Julián Medina; Lissa Cruz-Saavedra; Luz Helena Patiño; Marina Muñoz; Juan David Ramírez
Journal:  Parasit Vectors       Date:  2021-08-21       Impact factor: 3.876

2.  Establish an allele-specific real-time PCR for Leishmania species identification.

Authors:  Yun Wu; Mengyuan Jiang; Shaogang Li; Nicholas R Waterfield; Guowei Yang
Journal:  Infect Dis Poverty       Date:  2022-06-02       Impact factor: 10.485

3.  Alkyl and Aryl Derivatives Based on p-Coumaric Acid Modification and Inhibitory Action against Leishmania braziliensis and Plasmodium falciparum.

Authors:  Susiany P Lopes; Lina M Yepes; Yunierkis Pérez-Castillo; Sara M Robledo; Damião P de Sousa
Journal:  Molecules       Date:  2020-07-11       Impact factor: 4.411

4.  Phenotype Screening of an Azole-bisindole Chemical Library Identifies URB1483 as a New Antileishmanial Agent Devoid of Toxicity on Human Cells.

Authors:  Aurora Diotallevi; Laura Scalvini; Gloria Buffi; Yolanda Pérez-Pertejo; Mauro De Santi; Michele Verboni; Gianfranco Favi; Mauro Magnani; Alessio Lodola; Simone Lucarini; Luca Galluzzi
Journal:  ACS Omega       Date:  2021-12-15

5.  Data on the differentiation among Leishmania (Viannia) spp., Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis in Brazilian clinical samples using real-time PCR.

Authors:  Aurora Diotallevi; Gloria Buffi; Marcello Ceccarelli; Herintha Coeto Neitzke-Abreu; Laisa Vieira Gnutzmann; Manoel Sebastião da Costa Lima Junior; Alice Di Domenico; Mauro De Santi; Mauro Magnani; Luca Galluzzi
Journal:  Data Brief       Date:  2019-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.